학술논문
Intratumoral delivery of vector mediated IL-2 in combination with vaccine results in enhanced T cell avidity and anti-tumor activity
Document Type
Article
Source
In: Cancer Immunology, Immunotherapy . (Cancer Immunology, Immunotherapy, December 2007, 56(12):1897-1910)
Subject
Language
English
ISSN
03407004